- Home
- CNSP vs ATXG Comparison
CNSP vs ATXG Comparison
Compare CNSP & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- ATXG
- Stock Information
- Founded
- CNSP 2017
- ATXG 2014
- Country
- CNSP United States
- ATXG China
- Employees
- CNSP N/A
- ATXG N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- ATXG Professional Services
- Sector
- CNSP Health Care
- ATXG Consumer Discretionary
- Exchange
- CNSP Nasdaq
- ATXG Nasdaq
- Market Cap
- CNSP 4.0M
- ATXG 3.8M
- IPO Year
- CNSP 2019
- ATXG N/A
- Fundamental
- Price
- CNSP $6.19
- ATXG $0.55
- Analyst Decision
- CNSP Hold
- ATXG
- Analyst Count
- CNSP 1
- ATXG 0
- Target Price
- CNSP N/A
- ATXG N/A
- AVG Volume (30 Days)
- CNSP 79.4K
- ATXG 129.6K
- Earning Date
- CNSP 08-14-2025
- ATXG 08-14-2025
- Dividend Yield
- CNSP N/A
- ATXG N/A
- EPS Growth
- CNSP N/A
- ATXG N/A
- EPS
- CNSP N/A
- ATXG N/A
- Revenue
- CNSP N/A
- ATXG $4,310,835.00
- Revenue This Year
- CNSP N/A
- ATXG N/A
- Revenue Next Year
- CNSP N/A
- ATXG N/A
- P/E Ratio
- CNSP N/A
- ATXG N/A
- Revenue Growth
- CNSP N/A
- ATXG N/A
- 52 Week Low
- CNSP $4.93
- ATXG $0.36
- 52 Week High
- CNSP $221.94
- ATXG $1.86
- Technical
- Relative Strength Index (RSI)
- CNSP 42.48
- ATXG 53.61
- Support Level
- CNSP $5.85
- ATXG $0.44
- Resistance Level
- CNSP $6.37
- ATXG $0.58
- Average True Range (ATR)
- CNSP 0.68
- ATXG 0.05
- MACD
- CNSP 0.13
- ATXG 0.01
- Stochastic Oscillator
- CNSP 48.87
- ATXG 64.71
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.